Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors Beyond Progressive Disease: A Retrospective Analysis for Japanese Patients with Activating EGFR Mutations

MLA

Kazuhiro Asami, et al. “Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors Beyond Progressive Disease: A Retrospective Analysis for Japanese Patients with Activating EGFR Mutations.” Annals of Oncology, vol. 23, Oct. 2012, p. xi117. EBSCOhost, https://doi.org/10.1016/s0923-7534(20)32323-1.

APA

Kazuhiro Asami, T. Okuma, S. Kudoh, Y. Matsuda, N. Takeuchi, Akihito Kubo, Minoru Takada, Shinji Atagi, T. Mimori, Y. Maruyama, N. Omachi, K. Nishie, Akihiro Tamiya, Tomoya Kawaguchi, & Kyoichi Okishio. (2012). Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors Beyond Progressive Disease: A Retrospective Analysis for Japanese Patients with Activating EGFR Mutations. Annals of Oncology, 23, xi117. https://doi.org/10.1016/s0923-7534(20)32323-1

Chicago

Kazuhiro Asami, T. Okuma, S. Kudoh, Y. Matsuda, N. Takeuchi, Akihito Kubo, Minoru Takada, et al. 2012. “Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors Beyond Progressive Disease: A Retrospective Analysis for Japanese Patients with Activating EGFR Mutations.” Annals of Oncology 23 (October): xi117. doi:10.1016/s0923-7534(20)32323-1.